| Full Name | Rebecca Hayes |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 95 Pleasant St, Lynn, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063565893 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Hayes, 95 Pleasant St, Lynn, MA 01901-1524 Ph: (781) 581-4400 | Rebecca Hayes, 95 Pleasant St, Lynn, MA 01901-1524 Ph: (781) 581-4400 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
After back-to-back, eight-hour shifts at a chiropractor's office and a rehab center, Nirva arrived outside an elderly woman's house just in time to help her up the front steps.
Transgenomic, Inc. announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company's CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.
Cangene Corporation today reports that it has been advised by the Biomedical Advanced Research and Development Authority, an agency within the U.S. Department of Health and Human Services, that Cangene has been eliminated from the competitive range with respect to its bid on a contract for developing a treatment for acute radiation syndrome.
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new treatment avenue for the more precise and effective treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed with hormonal therapy.
› Verified 1 days ago
Ms. Wendy Fay Gillenson, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 95 Pleasant St, Lynn, MA 01901 Phone: 781-581-4400 | |
Ms. Sarah Catherine Eilers, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 269 Union St, Lynn, MA 01901 Phone: 781-477-7222 | |
Melanie Solomon, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 117 N Common St, Lynn, MA 01902 Phone: 781-598-2759 | |
Grace Bonaiuto, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 90 Ocallaghan Way, Lynn, MA 01905 Phone: 781-598-0287 | |
Mrs. Maylene Victoria Collado-wulff, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 20 Central Ave, Lynn, MA 01901 Phone: 781-586-6691 | |
Keisha Larosa, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16 City Hall Sq, Frc, Lynn, MA 01901 Phone: 339-883-2401 | |
Taylor Alyson Kurmis, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 101 Green St, Lynn, MA 01902 Phone: 781-593-9434 Fax: 781-691-7034 |